Simplify Logo

Full-Time

Senior Director Drug Safety and Pharmacovigilance

Confirmed live in the last 24 hours

Acadia Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc.

501-1,000 employees

Develops therapies for neurological disorders

Consulting
Biotechnology

Senior, Expert

Princeton, NJ, USA

Category
Physicians & Surgeons
Medical, Clinical & Veterinary
Required Skills
Communications
Word/Pages/Docs
PowerPoint/Keynote/Slides
Requirements
  • MD degree or equivalent with clinical post-training resulting in eligibility for a US medical board certification.
  • Targeting 12 years of relevant drug safety experience in the biotechnology/pharmaceutical industry, including safety leadership experience.
  • MPH or pharmacoepidemiology expertise desired.
  • Neurology, psychiatry, or CNS-related disease experience preferred.
  • Highly-developed scientific and analytical knowledge base and an excellent understanding of good pharmacovigilance practices and current regulations within drug safety.
  • Proficiency at creating and communicating a clear vision and activities to achieve functional area and/or organizational goals.
  • Strength in analysis, critical decision-making and bottom line accountability.
  • Working knowledge of validated drug safety databases (preferably ARGUS) and MedDRA.
  • Thorough understanding of U.S. pharmacovigilance regulations, GCP and International Conference on Harmonization (ICH) guidelines.
  • Extensive experience in authoring of all types of aggregate safety reports including setting a strategy to address potential safety issues.
  • In-depth understanding of the drug development process.
  • Extensive experience in partnering with vendors to achieve results.
  • Exceptional written and verbal communication skills.
  • Skilled at negotiating with business partners or managing and influencing senior level leaders regarding matters of significance to the organization.
  • Ability to think strategically at the executive level, implement change, incorporate innovation, and implement strategies throughout all levels of the organization.
  • Ability to build and sustain trusted relationships both internally and externally.
  • Proficient computer skills, including Argus, Microsoft Word, PowerPoint and Excel.
Responsibilities
  • Develop strategies, working with the Head of Safety, to achieve PV Medical Safety goals.
  • Along with the Head of Safety, represent PV in communications with health authorities such as the FDA.
  • Assess safety signals and trends and proactively manage any potential safety issues.
  • Formulate response strategies and author responses for health authority requests.
  • Determine the need for pharmacoepidemiology, including input and liaise with external pharmacoepidemiologists.
  • Ensure PV Medical Safety activities are performed in compliance with all applicable regulations and Acadia standards.
  • Assist with oversight of the vendor performing medical review of ICSRs and aggregate report on behalf of Acadia.
  • Perform medical review of serious adverse events from Acadia clinical trials.
  • Accountable for medical evaluation/interpretation of aggregate safety data of assigned product(s) including signal detection and evaluation, and ad hoc safety assessments.
  • Provide oversight for the safety aspects of clinical studies, and development and maintenance of the company core safety information.
  • Provide support for safety sections of clinical documents, including the review and approval of the safety portion of protocols, annual reports (DSUR), final study reports, IB and other documents as needed.
  • Lead development of Risk Management Plans, implementation and evaluation of their effectiveness.
  • Ensure safety issues are communicated to the appropriate stakeholders in a timely fashion.
  • Author analysis of similar events (AOSE) and individual case comments for ICSRs.
  • Maintain knowledge of global regulatory authority regulations including FDA and EMA.
  • Contribute to the training, leadership and continuing education of department staff.
  • Other duties as assigned.
Acadia Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc.

View

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. Their products are created through extensive research and development, followed by rigorous clinical trials to ensure safety and effectiveness. Once approved by regulatory bodies like the FDA, these therapies are marketed to patients and healthcare providers. Acadia stands out from competitors by concentrating on areas with significant unmet medical needs and fostering strategic partnerships to enhance their research and market presence. The company's goal is to improve the quality of life for individuals with neurological conditions through effective treatments.

Company Stage

IPO

Total Funding

$813.4M

Headquarters

Dallas, Texas

Founded

1993

Simplify Jobs

Simplify's Take

What believers are saying

  • Acadia's launch of Magnolia's Guide to Adventuring showcases their innovative approach to raising disease awareness and redefining perceptions of Rett syndrome.
  • The acceptance of trofinetide for priority review by Health Canada could lead to significant market expansion and first-mover advantage in treating Rett syndrome in Canada.
  • The appointment of Dr. Elizabeth H. Z. Thompson as Executive Vice President, Head of Research and Development, signals a strong commitment to advancing their R&D capabilities.

What critics are saying

  • The failure of the Phase III ADVANCE-2 trial for pimavanserin in schizophrenia highlights the high-risk nature of drug development in the biopharmaceutical sector.
  • Dependence on regulatory approvals, such as the FDA and Health Canada, introduces uncertainty and potential delays in bringing therapies to market.

What makes Acadia Pharmaceuticals Inc. unique

  • Acadia Pharmaceuticals focuses exclusively on neurological disorders, setting it apart from competitors with broader therapeutic areas.
  • Their commitment to corporate social responsibility, including initiatives like the Rett Sibling Scholarship, enhances their reputation and community engagement.
  • Acadia's strategic partnerships and corporate sponsorships amplify their research capabilities and market reach, distinguishing them from competitors who may not leverage such collaborations.